| C-0101 | (Trp63,Trp64)-C3a (63-77) | C86H134N26O18 | 1820.17 | 130154-64-2 | H-Trp-Trp-Gly-Lys-Lys-Tyr-Arg-Ala-Ser-Lys-Leu-Gly-Leu-Ala-Arg-OH |
| C-0102 | (Tyr69,Ala71·72,Lys74)-C3a (69-77) | C45H77N13O11 | 976.19 | 145702-79-0 | H-Tyr-Ala-Ala-Ala-Leu-Lys-Leu-Ala-Arg-OH |
| C-0103 | C3a (70-77) | C35H61N13O10 | 823.95 | 63555-63-5 | H-Ala-Ser-His-Leu-Gly-Leu-Ala-Arg-OH Trifluoroacetate salt |
| C-0103-2 | (β-Ala70)-C3a (70-77) | C35H61N13O10 | 823.95 | 105931-71-3 | H-β-Ala-Ser-His-Leu-Gly-Leu-Ala-Arg-OH |
| C-0103-3 | (Fmoc-Glu70,Ala71·72,Lys74)-C3a (70-77) | C53H80N12O13 | 1093.29 | Fmoc-Glu-Ala-Ala-Leu-Lys-Leu-Ala-Arg-OH | |
| C-0104 | C3a (72-77) (human) | C29H51N11O7 | 665.79 | 66157-45-7 | H-His-Leu-Gly-Leu-Ala-Arg-OH |
| C-0105 | C3d Peptide P16 | C86H131N25O27 | 1947.14 | 99027-06-2 | H-Lys-Asn-Arg-Trp-Glu-Asp-Pro-Gly-Lys-Gln-Leu-Tyr-Asn-Val-Glu-Ala-OH |
| C-0201 | C5a Anaphylatoxin (37-53) (human) PL37 |
C82H141N27O22S | 1889.26 | 706808-05-1 | H-Arg-Ala-Ala-Arg-Ile-Ser-Leu-Gly-Pro-Arg-Cys-Ile-Lys-Ala-Phe-Thr-Glu-OH |
| C-0202 | (Tyr65,Phe67)-C5a (65-74) (human) | C55H85N15O16S | 1244.44 | H-Tyr-Ser-Phe-Lys-Asp-Met-Gln-Leu-Gly-Arg-OH | |
| C-0203 | C5a Inhibitory Sequence | C51H86N12O9 | 1011.32 | 133214-60-5 | H-Phe-Lys-Ala-β-cyclohexyl-Ala-β-cyclohexyl-Ala-Leu-D-Ala-Arg-OH |
